{
    "info": {
        "nct_id": "NCT06213298",
        "official_title": "Effect of Kava on Anxiety and Stress in Cancer Survivors",
        "inclusion_criteria": "* Completed curative-intent treatment for breast, gynecologic, lung, or head/neck cancer within the last 24 months without clinical and/or radiographic evidence of recurrence at the time of the last follow up\n* Score of ≥ 5 on the GAD-7 questionnaire, considered to be mild anxiety\n* ECOG performance status 0-1\n* Normal kidney and liver function within 28 days prior to the first dose of kava or placebo\n* Willing to abstain from benzodiazepine and alcohol use during the kava or placebo intervention and for at least 14 days after completion\n* Ability to provide written, informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Regular use of benzodiazepines, defined as ≥ 2 times weekly, within 14 days prior to study registration\n* Anti-cancer therapy within 28 days prior to registration, and/or during study participation, except for aromatase inhibitors\n* Known liver disease such as cirrhosis (any Child-Pugh class), active infectious hepatitis, immune-mediated hepatitis, hemochromatosis, non-alcoholic steatohepatitis (NASH), or Wilson's disease\n* Use of acetaminophen at doses more than 2000 mg daily for more than three days per week within 7 days prior to the first dose of kava or placebo intervention\n* Chronic use of high-intensity statin therapy\n* Significant uncontrolled conditions or situations, which in the judgment of the enrolling investigator, could affect safety and/or ability to adhere to study requirements\n* Adjustments in anti-depressants and/or anxiolytic medications within 8 weeks prior to study registration\n* Known allergy to kava\n* Women who are pregnant, intend to become pregnant, or are nursing\n* Regular use of alcohol, defined as ≥ 3 times per week, regardless of amount, within 14 days prior to study registration\n* Parkinson's disease\n* History of or current substance use disorder by self-report",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status 0-1",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status 0-1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willing to abstain from benzodiazepine and alcohol use during the kava or placebo intervention and for at least 14 days after completion",
            "criterions": [
                {
                    "exact_snippets": "Willing to abstain from benzodiazepine ... during the kava or placebo intervention and for at least 14 days after completion",
                    "criterion": "benzodiazepine use",
                    "requirements": [
                        {
                            "requirement_type": "abstinence_duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 14,
                                        "unit": "days"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Willing to abstain from ... alcohol use during the kava or placebo intervention and for at least 14 days after completion",
                    "criterion": "alcohol use",
                    "requirements": [
                        {
                            "requirement_type": "abstinence_duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 14,
                                        "unit": "days"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to provide written, informed consent",
            "criterions": [
                {
                    "exact_snippets": "Ability to provide written, informed consent",
                    "criterion": "ability to provide informed consent",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "consent type",
                            "expected_value": "written, informed"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Score of ≥ 5 on the GAD-7 questionnaire, considered to be mild anxiety",
            "criterions": [
                {
                    "exact_snippets": "Score of ≥ 5 on the GAD-7 questionnaire",
                    "criterion": "GAD-7 questionnaire score",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 5,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Normal kidney and liver function within 28 days prior to the first dose of kava or placebo",
            "criterions": [
                {
                    "exact_snippets": "Normal kidney ... within 28 days prior to the first dose",
                    "criterion": "kidney function",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "normal"
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days prior to first dose"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Normal ... liver function within 28 days prior to the first dose",
                    "criterion": "liver function",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "normal"
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days prior to first dose"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Completed curative-intent treatment for breast, gynecologic, lung, or head/neck cancer within the last 24 months without clinical and/or radiographic evidence of recurrence at the time of the last follow up",
            "criterions": [
                {
                    "exact_snippets": "Completed curative-intent treatment for breast, gynecologic, lung, or head/neck cancer",
                    "criterion": "curative-intent treatment for breast, gynecologic, lung, or head/neck cancer",
                    "requirements": [
                        {
                            "requirement_type": "completion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "within the last 24 months",
                    "criterion": "time since completion of curative-intent treatment",
                    "requirements": [
                        {
                            "requirement_type": "time since completion",
                            "expected_value": {
                                "operator": "<=",
                                "value": 24,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "without clinical and/or radiographic evidence of recurrence at the time of the last follow up",
                    "criterion": "evidence of recurrence",
                    "requirements": [
                        {
                            "requirement_type": "clinical evidence of recurrence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "radiographic evidence of recurrence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Parkinson's disease",
            "criterions": [
                {
                    "exact_snippets": "Parkinson's disease",
                    "criterion": "Parkinson's disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of or current substance use disorder by self-report",
            "criterions": [
                {
                    "exact_snippets": "History of or current substance use disorder by self-report",
                    "criterion": "substance use disorder",
                    "requirements": [
                        {
                            "requirement_type": "history or current presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment method",
                            "expected_value": "self-report"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Use of acetaminophen at doses more than 2000 mg daily for more than three days per week within 7 days prior to the first dose of kava or placebo intervention",
            "criterions": [
                {
                    "exact_snippets": "Use of acetaminophen at doses more than 2000 mg daily for more than three days per week within 7 days prior to the first dose of kava or placebo intervention",
                    "criterion": "acetaminophen use",
                    "requirements": [
                        {
                            "requirement_type": "dose",
                            "expected_value": {
                                "operator": ">",
                                "value": 2000,
                                "unit": "mg/day"
                            }
                        },
                        {
                            "requirement_type": "frequency",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "days/week"
                            }
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": "within 7 days prior to the first dose of kava or placebo intervention"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known liver disease such as cirrhosis (any Child-Pugh class), active infectious hepatitis, immune-mediated hepatitis, hemochromatosis, non-alcoholic steatohepatitis (NASH), or Wilson's disease",
            "criterions": [
                {
                    "exact_snippets": "Known liver disease such as cirrhosis (any Child-Pugh class)",
                    "criterion": "liver disease (cirrhosis)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active infectious hepatitis",
                    "criterion": "infectious hepatitis",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    ]
                },
                {
                    "exact_snippets": "immune-mediated hepatitis",
                    "criterion": "immune-mediated hepatitis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hemochromatosis",
                    "criterion": "hemochromatosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "non-alcoholic steatohepatitis (NASH)",
                    "criterion": "non-alcoholic steatohepatitis (NASH)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Wilson's disease",
                    "criterion": "Wilson's disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Regular use of benzodiazepines, defined as ≥ 2 times weekly, within 14 days prior to study registration",
            "criterions": [
                {
                    "exact_snippets": "Regular use of benzodiazepines, defined as ≥ 2 times weekly, within 14 days prior to study registration",
                    "criterion": "benzodiazepine use",
                    "requirements": [
                        {
                            "requirement_type": "frequency",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "times per week"
                            }
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days prior to study registration"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Women who are pregnant, intend to become pregnant, or are nursing",
            "criterions": [
                {
                    "exact_snippets": "Women who are pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnant",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "intend to become pregnant",
                    "criterion": "pregnancy intention",
                    "requirements": [
                        {
                            "requirement_type": "intention to become pregnant",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "are nursing",
                    "criterion": "nursing status",
                    "requirements": [
                        {
                            "requirement_type": "nursing",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Significant uncontrolled conditions or situations, which in the judgment of the enrolling investigator, could affect safety and/or ability to adhere to study requirements",
            "criterions": [
                {
                    "exact_snippets": "Significant uncontrolled conditions or situations",
                    "criterion": "uncontrolled conditions or situations",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "which in the judgment of the enrolling investigator, could affect safety and/or ability to adhere to study requirements",
                    "criterion": "potential to affect safety or study adherence",
                    "requirements": [
                        {
                            "requirement_type": "potential impact",
                            "expected_value": [
                                "safety",
                                "ability to adhere to study requirements"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known allergy to kava",
            "criterions": [
                {
                    "exact_snippets": "Known allergy to kava",
                    "criterion": "allergy to kava",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Regular use of alcohol, defined as ≥ 3 times per week, regardless of amount, within 14 days prior to study registration",
            "criterions": [
                {
                    "exact_snippets": "Regular use of alcohol, defined as ≥ 3 times per week, regardless of amount, within 14 days prior to study registration",
                    "criterion": "alcohol use",
                    "requirements": [
                        {
                            "requirement_type": "frequency",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "times per week"
                            }
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days prior to study registration"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Chronic use of high-intensity statin therapy",
            "criterions": [
                {
                    "exact_snippets": "Chronic use of high-intensity statin therapy",
                    "criterion": "high-intensity statin therapy",
                    "requirements": [
                        {
                            "requirement_type": "chronic use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adjustments in anti-depressants and/or anxiolytic medications within 8 weeks prior to study registration",
            "criterions": [
                {
                    "exact_snippets": "Adjustments in anti-depressants and/or anxiolytic medications within 8 weeks prior to study registration",
                    "criterion": "anti-depressant medication",
                    "requirements": [
                        {
                            "requirement_type": "adjustment_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 8,
                                "unit": "weeks prior to study registration"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Adjustments in anti-depressants and/or anxiolytic medications within 8 weeks prior to study registration",
                    "criterion": "anxiolytic medication",
                    "requirements": [
                        {
                            "requirement_type": "adjustment_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 8,
                                "unit": "weeks prior to study registration"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "* Anti-cancer therapy within 28 days prior to registration, and/or during study participation, except for aromatase inhibitors",
            "criterions": [
                {
                    "exact_snippets": "Anti-cancer therapy within 28 days prior to registration",
                    "criterion": "anti-cancer therapy",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days prior to registration"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "anti-cancer therapy ... during study participation",
                    "criterion": "anti-cancer therapy",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": "during study participation"
                        }
                    ]
                },
                {
                    "exact_snippets": "except for aromatase inhibitors",
                    "criterion": "aromatase inhibitors",
                    "requirements": [
                        {
                            "requirement_type": "exception",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}